443 results on '"Sill, H."'
Search Results
2. Core-binding factor leukemia hijacks the T-cell–prone PU.1 antisense promoter
3. Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS
4. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: A STEP TOWARDS IDENTIFICATION AND CAUSAL INTERPRETATION OF THERAPY-RELATED MDS (T-MDS)
5. Overexpression of miR-23a, miR-24 and miR- 15a in acute myeloid leukemia with loss of the RAF kinase inhibitor protein
6. Loss of the tumor- and metastasis suppressor RAF kinase inhibitor protein is caused by the overexpression of miRNA-23a [Abstract]
7. Loss of the tumor- and metastasis suppressor RAF kinase inhibitor protein is caused by the overexpression of miRNA-23a [Poster]
8. Translation initiation factors as novel prognostic biomarkers of aggressive b-cell lymphomas [Poster]
9. Translation initiation factors are over-expressed in aggressive lymphomas and influence their clinical course [Poster]
10. P091 - Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: A STEP TOWARDS IDENTIFICATION AND CAUSAL INTERPRETATION OF THERAPY-RELATED MDS (T-MDS)
11. A microRNA-mediated regulatory loop modulates NOTCH and MYC oncogenic signals in B- and T-cell malignancies
12. O29 - Topic: AS02-Epidemiology: COMPARISON OF CYTOGENETIC ABERRATIONS IN 1590 PATIENTS WITH THERAPY-RELATED MDS (T-MDS) AND 4738 PATIENTS FROM THE REVISED INTERNATIONAL PROGNOSTIC SCORING SYSTEM DATABASE WITH PRIMARY-MDS (P-MDS)
13. Topic: AS02-Epidemiology
14. Ein besonderer Fall einer Hyperkalzämie
15. Genome-wide association study identifies susceptibility loci for acute myeloid leukemia
16. Frequent loss of RAF kinase inhibitor protein expression in acute myeloid leukemia
17. Reduced-intensity allografting in patients with therapy-related myeloid neoplasms and active primary malignancies
18. Loss of RAF kinase inhibitor protein is a somatic event in the pathogenesis of therapy-related acute myeloid leukemias with C-RAF germline mutations
19. All-transretinoic acid in non-promyelocytic acute myeloid leukemia: driver lesion dependent effects on leukemic stem cells
20. Phenotyping and Target Expression Profiling of CD34+/CD38− and CD34+/CD38+ Stem- and Progenitor cells in Acute Lymphoblastic Leukemia
21. Evaluation of potential risk factors for early infectious complications after autologous peripheral blood stem cell transplantation in patients with lymphoproliferative diseases
22. RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implications
23. High expression of the sister-chromatid separation regulator and proto-oncogene hSecurin occurs in a subset of myeloid leukaemias but is not implicated in the pathogenesis of aneuploidy
24. High-risk AML complicated by pulmonary aspergillosis: successful treatment with nonmyeloablative stem cell transplantation and long-term administration of voriconazole
25. Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignancies
26. Mutant DNMT3A in acute myeloid leukemia: guilty of inducing genetic instability?
27. Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma
28. Acute myelofibrosis: multifocal bone marrow infiltration detected by scintigraphy and magnetic resonance imaging
29. The RAF kinase inhibitor protein acts as a novel tumor suppressor in acute myeloid leukemia: V715
30. Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies
31. UCBT with low-dose ATG in adults: P541
32. Therapy-related myeloid neoplasms: pathobiology and clinical characteristics
33. Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS
34. Core binding factor leukemia hijacks T-cell prone PU.1 antisense promoter
35. Loss of RAF kinase inhibitor protein is a somatic event in the pathogenesis of therapy-related acute myeloid leukemias with C-RAF germline mutations: B2.28
36. Rarity of dominant-negative mutations of the G-CSF receptor in patients with blast crisis of chronic myeloid leukemia or de novo acute leukemia
37. The commonly deleted region at 9p21-22 in lymphoblastic leukemias spans at least 400 kb and includes p16 but not p15 or the IFN gene cluster
38. Iron overload in myelodysplastic syndromes (MDS) – diagnosis, management, and response criteria: a proposal of the Austrian MDS platform
39. Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: long-term results of a multicenter phase-II study
40. Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome
41. Hodgkin's disease developing after spontaneous remission of chronic lymphocytic leukemia
42. Pulmonary infiltrates in patients with haematologic malignancies: transbronchial lung biopsy increases the diagnostic yield with respect to neoplastic infiltrates and toxic pneumonitis
43. Therapy-related leukemia cutis: case study of an aggressive disorder
44. Planned sequential autologous/non-myeloablative allogeneic peripheral stem cell transplantation in patients with newly diagnosed high-risk multiple myeloma
45. Bedside RNA stabilizing kit systems for gene expression analysis of acute leukemias: influence of non-neoplastic white blood cells
46. Risk Factors for Early Infectious Complications after Autologous Peripheral Blood Stem Cell Transplantation in Patients with Hematopoietic Malignancies: O79
47. Autologous stem cell transplantation for multiple myeloma in elderly patients
48. Continuous molecular response after discontinuation of imatinib mesylate following relapse after non-myeloablative allogeneic stem cell transplantation for CML
49. High expression of the sister-chromatid separation regulator and proto-oncogene hSecurin occurs in a subset of myeloid leukaemias but is not implicated in the pathogenesis of aneuploidy: P1061
50. Detection of catheter-related blood stream infection by the AOLC and DTP method in neutropenic patients after hematopoietic stem cell transplantation: P807
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.